Skip to main content

Christopher Wildrick Woods

Wolfgang Joklik Distinguished Professor of Global Health
Medicine, Infectious Diseases
310 Trent Drive, Duke Box #90519, Durham, NC 27708

Overview


1. Emerging Infections
2. Global Health
3. Epidemiology of infectious diseases
4. Clinical microbiology and diagnostics
5. Bioterrorism Preparedness
6. Surveillance for communicable diseases
7. Antimicrobial resistance

Current Duke Appointments & Affiliations


Wolfgang Joklik Distinguished Professor of Global Health · 2023 - Present Medicine, Infectious Diseases, Medicine
Professor of Medicine · 2014 - Present Medicine, Infectious Diseases, Medicine
Associate Director of Duke Center for Applied Genomics and Precision Medicine · 2014 - Present The Precision Medicine Program, Medicine
Research Professor of Global Health · 2011 - Present Duke Global Health Institute, University Institutes and Centers
Professor in Pathology · 2014 - Present Pathology, Clinical Science Departments
Member of the Duke Human Vaccine Institute · 2023 - Present Duke Human Vaccine Institute, Institutes and Centers

Recent News Items


Published March 29, 2024
Center for Precision Health Welcomes New Faculty Leaders
Published September 18, 2023
Where Will the Next Pandemic Come From?
Published May 4, 2023
Duke Awards 44 Distinguished Professorships

View All News Items

Recent Scholarly Works


Innate immune responsiveness predicts enhanced cellular immunity and symptomatic disease after controlled human influenza infection.

Journal article Nat Med · July 2026 Controlled human influenza infection studies can uniquely interrogate the early immune factors associated with clinical outcome. In this study, 27 healthy volunteers with low strain-specific serum neutralizing antibody levels were challenged with influenza ... Full text Link to item Cite

Influenza coinfection inhibits control of mycobacterial infection in a human challenge model.

Journal article Nat Commun · June 11, 2026 Mycobacterium tuberculosis infection is a dynamic continuum. Clinical outcomes reflect complex host-pathogen interactions. Epidemiological and animal studies have suggested influenza coinfection as a risk factor for progression from contained infection to ... Full text Link to item Cite

Cytomegalovirus DNAemia in Hospitalized Adults With SARS-CoV-2 Infection Requiring Supplemental Oxygen: Virologic and Clinical Characteristics and Association With Outcomes.

Journal article J Infect Dis · May 15, 2026 BACKGROUND: Cytomegalovirus (CMV) reactivation occurs in the context of coronavirus disease 2019 (COVID-19); however, the viral kinetics, risk factors, and clinical outcomes are poorly defined. METHODS: We examined the association of CMV DNAemia with clini ... Full text Link to item Cite
View All Scholarly Works

Recent Grants


Interdisciplinary Research Training Program in AIDS

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2010 - 2030

Multiscale Modeling of Influenza Neutralizing Antibody and Fc Effector Biology

ResearchInvestigator · Awarded by National Institute of Allergy and Infectious Diseases · 2024 - 2029

Stimulating Access to Research in Residency (StARR) - NIAID

Inst. Training Prgm or CMEPreceptor · Awarded by National Institute of Allergy and Infectious Diseases · 2018 - 2029

View All Grants

Education


Duke University · 1994 M.D.